Literature DB >> 22062939

Intractable childhood epilepsy: choosing between the treatments.

Eric H Kossoff1.   

Abstract

Intractable epilepsy is a significant problem affecting approximately 1 in 10 children with seizures. This is traditionally defined as a failure to respond to at least 2 anticonvulsant drugs tried at reasonable doses for several weeks. Although involving a minority of those with epilepsy, these children typically have significant morbidity, detrimental effects on quality of life, and often require hours of time from a child neurologist in their care. In this review and special issue, a practical approach to management options for children who have refractory epilepsy will be presented from experts in the field. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22062939     DOI: 10.1016/j.spen.2011.06.001

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  6 in total

1.  Treatment of epilepsy in daily clinical practice: have outcomes improved over the past 10 years?

Authors:  Merel Wassenaar; Inger van Heijl; Frans S S Leijten; Paul van der Linden; Sabine G Uijl; A C G Egberts; J A Carpay
Journal:  J Neurol       Date:  2013-07-28       Impact factor: 4.849

Review 2.  Refractory epilepsy in children.

Authors:  Satinder Aneja; Puneet Jain
Journal:  Indian J Pediatr       Date:  2014-08-09       Impact factor: 1.967

3.  Drosophila as a model for intractable epilepsy: gilgamesh suppresses seizures in para(bss1) heterozygote flies.

Authors:  Iris C Howlett; Zeid M Rusan; Louise Parker; Mark A Tanouye
Journal:  G3 (Bethesda)       Date:  2013-08-07       Impact factor: 3.154

4.  Case Report: Laser Ablation Guided by State of the Art Source Imaging Ends an Adolescent's 16-Year Quest for Seizure Freedom.

Authors:  Christos Papadelis; Shannon E Conrad; Yanlong Song; Sabrina Shandley; Daniel Hansen; Madhan Bosemani; Saleem Malik; Cynthia Keator; M Scott Perry
Journal:  Front Hum Neurosci       Date:  2022-01-25       Impact factor: 3.169

5.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

6.  Who receives home-based perinatal palliative care: experience from Poland.

Authors:  Aleksandra Korzeniewska-Eksterowicz; Łukasz Przysło; Bogna Kędzierska; Małgorzata Stolarska; Wojciech Młynarski
Journal:  Biomed Res Int       Date:  2013-09-03       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.